These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 66523)

  • 21. The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
    Kutlugün AA; Altun B; Aktan U; Turkmen E; Altindal M; Yildirim T; Yilmaz R; Arici M; Erdem Y; Turgan C
    Amyloid; 2012 Mar; 19(1):28-32. PubMed ID: 22320202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal protein clearances and selectivity of proteinuria in renal amyloid complicating familial Mediterranean fever.
    Poreh S; Berlyne GM
    Nephron; 1974; 13(3):221-9. PubMed ID: 4421688
    [No Abstract]   [Full Text] [Related]  

  • 23. Pattern of proteinuria in patients with renal amyloidosis secondary to familial Mediterranean fever.
    Colakoglu M; Sungur C; Sungur A; Akpolat T; Kansu E; Yasavul U; Turgan C; Caglar S
    Nephron; 1995; 69(1):124. PubMed ID: 7891791
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of dimethyl sulfoxide (DMSO) upon spontaneous amyloidosis in mice.
    Eisenbud LE; Lerner CP; Chai CK
    Proc Soc Exp Biol Med; 1981 Nov; 168(2):172-4. PubMed ID: 7348302
    [No Abstract]   [Full Text] [Related]  

  • 25. Amyloid--the great pretender.
    Korzets Z; Golan E; Bernheim J; Bernheim J
    Nephrol Dial Transplant; 1995 Oct; 10(10):1938-9. PubMed ID: 8592611
    [No Abstract]   [Full Text] [Related]  

  • 26. Uncertain value of urinary sediments in the diagnosis of amyloidosis.
    Shirahama T; Skinner M; Cohen AS; Benson MD
    N Engl J Med; 1977 Oct; 297(15):821-3. PubMed ID: 408688
    [No Abstract]   [Full Text] [Related]  

  • 27. DMSO and colchicine therapy in amyloid disease.
    Scheinberg MA; Pernambuco JC; Benson MD
    Ann Rheum Dis; 1984 Jun; 43(3):421-3. PubMed ID: 6742905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of "primary" renal amyloidosis with melphalan.
    Jones NF; Hilton PJ; Tighe JR; Hobbs JR
    Lancet; 1972 Sep; 2(7778):616-9. PubMed ID: 4116774
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renal amyloidosis].
    Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
    Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical variants and masks of renal amyloidosis].
    Shulutko BI; Tsykin DB
    Ter Arkh; 1987; 59(10):94-7. PubMed ID: 3433229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
    Kahvecioglu S; Dilek K; Akdag I; Gullulu M; Demircan C; Ersoy A; Yurtkuran M
    Nephrology (Carlton); 2006 Jun; 11(3):232-7. PubMed ID: 16756637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the clinical picture of renal amyloidosis].
    Mukhin NA; Khasabov NN; Savitskiĭ SN; Dzgoeva FU; Dziuba MT
    Urol Nefrol (Mosk); 1980; (3):7-11. PubMed ID: 7385482
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
    Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
    Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosis.
    Lim KB; Tan SH; Tan KT
    Br J Dermatol; 1988 Sep; 119(3):409-10. PubMed ID: 3179214
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pleural amyloidosis].
    Kanoh T
    Rinsho Ketsueki; 1996 Nov; 37(11):1293-6. PubMed ID: 8960664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary localized amyloidosis of the bladder: a case of AL (lambda) amyloid protein and combination therapy using dimethyl sulfoxide and cepharanthin.
    Nishiyama T; Gejyo F; Katayama Y; Takeda M; Takeda M; Sato S
    Urol Int; 1992; 48(2):228-31. PubMed ID: 1585522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Secondary (AA) amyloidosis in Crohn's disease].
    Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
    Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine use in isolated renal AA amyloidosis.
    Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
    Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and differential diagnosis of renal light chain-associated diseases.
    Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
    Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
    Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.